NATIONAL CANCER CONTROL PROGRAMME
NOP online
ISSN 1802-887X
CANCON
 
data and background information All projects

All projects

Breast

Breast

Terminated clinical registry of breast cancer patients who were treated with trastuzumab (Herceptin®), lapatinib (Tyverb®), bevacizumab (Avastin®) and/or everolimus (Afinitor®).

CANCON – European Guide on Quality Improvement in Comprehensive Cancer Control

CANCON – European Guide on Quality Improvement in Comprehensive Cancer Control

Based on the Czech information system of cancer care, the Czech Republic has been selected as a model country for the development of a Comprehensive Cancer Care Network (CCCN).

Cervix.cz – Cervical Cancer Screening Programme in the Czech Republic

Cervix.cz – Cervical Cancer Screening Programme in the Czech Republic

System of informational support for the Cervical Cancer Screening Programme in the Czech Republic.

Corect

Corect

Terminated clinical registry of colorectal cancer (CRC) patients who were treated with cetuximab (Erbitux®), bevacizumab (Avastin®) and/or panitumumab (Vectibix®).

CyRUS – Cystectomy Registry of the Czech Urological Society

CyRUS – Cystectomy Registry of the Czech Urological Society

Clinical registry monitoring cases of bladder cancers treated with cystectomy and consecutive treatment.

Data and projects of the Czech Society for Oncology

Data and projects of the Czech Society for Oncology

The Czech Society for Oncology (CSO) is the principal authority coordinating cancer-related activities in the Czech Republic.

I-COP: Information centre for cancer care facilities

I-COP: Information centre for cancer care facilities

Informational and analytical platform enabling the evaluation of complex aspects of health care provided to cancer patients in particular.

Kolorektum.cz – Colorectal Cancer Screening Programme in the Czech Republic

Kolorektum.cz – Colorectal Cancer Screening Programme in the Czech Republic

System of informational support for the Colorectal Cancer Screening Programme in the Czech Republic.

Mamo.cz – Breast Cancer Screening Programme in the Czech Republic

Mamo.cz – Breast Cancer Screening Programme in the Czech Republic

System of informational support for the Breast Cancer Screening Programme in the Czech Republic.

Melanom

Melanom

Clinical registry of melanoma patients who have been treated with dabrafenib (Tafinlar®), ipilimumab (Yervoy®), nivolumab (Opdivo®), trametinib (Mekinist®), pembrolizumab (Keytruda®) and/or vemurafenib (Zelboraf®).

NOP On-line

NOP On-line

Project based on the development of a web portal containing detailed information on cancer care provided in the Czech Republic and on current nationwide projects focused on cancer prevention and cancer research.
OVARIA

OVARIA

Terminated clinical registry of ovarian cancer patients who were treated with bevacizumab (Avastin®) and/or olaparib (Lynparza®).

Pemetrexed

Pemetrexed

Clinical registry of pleural mesothelioma patients who have been treated with pemetrexed (Alimta®).

PET/CT-CZ(Q)

PET/CT-CZ(Q)

Terminated project developing a data background for the monitoring of numbers and indications of PET/CT scans in the clinical practice of Czech health care facilities.

reGISTer

reGISTer

Terminated clinical registry that monitored the epidemiology of gastrointestinal stromal tumours (GIST) as well as therapeutic approaches and treatment results in GIST patients in the Czech Republic and Slovakia.

Rektum.cz

Rektum.cz

The portal rektum.cz is dedicated mainly to the education of health care professionals on the issue of rectal cancer, which is diagnosed as C20 under the ICD-10 classification.

RenIS

RenIS

Terminated clinical registry of kidney cancer patients who were treated with bevacizumab (Avastin®), everolimus (Afinitor®), pazopanib (Votrient®), sorafenib (Nexavar®), sunitinib (Sutent®) and/or temsirolimus (Torisel®).

SVOD: Cancer epidemiology in the Czech Republic

SVOD: Cancer epidemiology in the Czech Republic

Research project based on the development of a web portal about the cancer epidemiology in the Czech Republic. Its primary objective is to provide access to these valuable data to a wide spectrum of users from the Czech Republic as well as from abroad.

Tulung

Tulung

Clinical registry of non-small cell lung cancer (NSCLC) patients who have been treated with bevacizumab (Avastin®), erlotinib (Tarceva®), gefitinib (Iressa®), pemetrexed (Alimta®), afatinib (Giotrif®) and/or nintedanib (Vargatef®).

Uroweb

Uroweb

Presentation of data and strategic importance in the Czech urology as regards the treatment of urological malignancies.